Clinical Trials
2 trialsNCT01548911 2018-07-02
Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT00670150 2015-10-27
New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia
University of Southern California
Phase 2 Withdrawn